Media
|
Contact
|
Disclaimer
|
Careers
About us
Vision & Mission
Goal & Strategy
Values
Board of Directors
Management
Global Oncology Advisory Board
Business Development
Oncology
Cancer at a glance
Belinostat
Mode of action
Clinical use
Safety profile
Indications and clinical program
Belinostat clinical studies
Other clinical studies
NCI- and Investigator Sponsored Trials
Science
Histone Deacetylase (HDAC)
Scientific publications
Glossary
Collaborators
Academic collaborators
Partners
Investor
About us
Vision & Mission
Goal & Strategy
Values
Board of Directors
Management
Francois Martelet
Axel Mescheder
Anders Fink Vadsholt
Inge Holm Lauritzen
Elisabeth V. Carstensen
Global Oncology Advisory Board
Business Development
The Management
Francois Martelet
Chief Executive Officer
Axel Mescheder
Chief Medical & Development Officer
Anders Fink Vadsholt
Chief Financial Officer
Inge Holm Lauritzen
VP Business Development & Licensing/Strategic Planning
Elisabeth V. Carstensen
Director of Pharmaceutical Operations